Shenandoah Acquisition Corp is 10% Owner at Sigilon Therapeutics, Inc. (SGTX). They have made 1 open-market trade across 1 company since 2023, most recently 2023-08-11.
CIK 0001983165
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $51.3M since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SGTX | 100 | $2K |
Shares reported on the most recent Form 4, priced at the 2023-08-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGTX | BUY | 2023-08-11 | 2023-08-14 | $14.92 | $51.3M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.